These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Steroids in the Guillain-Barré syndrome: is there a therapeutic window? Van Koningsveld R; Van Doorn PA Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470 [No Abstract] [Full Text] [Related]
24. Guillain-Barré syndrome presenting with loss of taste. Odaka M; Yuki N; Nishimoto Y; Hirata K Neurology; 2002 May; 58(9):1437-8. PubMed ID: 12011304 [No Abstract] [Full Text] [Related]
25. [Treatment of Guillain-Barré Syndrome]. Nomura K Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955 [TBL] [Abstract][Full Text] [Related]
26. [Guillain-Barré syndrome]. Koga M; Yuki N Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101 [No Abstract] [Full Text] [Related]
28. [Case report; A case of anti-GD1b antibody positive pure motor form Guillain-Barré syndrome with good response to combined IVIg and steroid therapy]. Fujimoto T; Fukuda Y; Eguchi K; Kusunoki S Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1651-3. PubMed ID: 21770292 [No Abstract] [Full Text] [Related]
29. [Guillain-Barré syndrome associated with acute hepatitis A-A case report and literature review]. Saito A; Saito M; Shimoe Y; Yoshimoto T; Kawakami M; Okamoto H; Yoshikawa K; Kusunoki S; Kuriyama M Rinsho Shinkeigaku; 2018 Sep; 58(9):574-577. PubMed ID: 30175808 [TBL] [Abstract][Full Text] [Related]
30. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Korinthenberg R Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847 [No Abstract] [Full Text] [Related]
31. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies. Tobon A J Infus Nurs; 2017; 40(6):375-379. PubMed ID: 29112586 [TBL] [Abstract][Full Text] [Related]
32. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis. Dididze MN Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218 [TBL] [Abstract][Full Text] [Related]
33. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study. Garssen MP; van Koningsveld R; van Doorn PA; Merkies IS; Scheltens-de Boer M; van Leusden JA; van Schaik IN; Linssen WH; Visscher F; Boon AM; Faber CG; Meulstee J; Prick MJ; van den Berg LH; Franssen H; Hiel JA; van den Bergh PY; Sindic CJ J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):1012-3. PubMed ID: 17702789 [No Abstract] [Full Text] [Related]
34. [Simultaneous bilateral peripheral facial paralysis is a rare variant of Guillain-Barré syndrome]. Frahm-Falkenberg S; de la Cour CD; Andersen PB Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293855 [TBL] [Abstract][Full Text] [Related]
35. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis. Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414 [TBL] [Abstract][Full Text] [Related]